Severe primary axillary hyperhidrosis—more commonly referred to as excessive sweating — is a distressing condition which usually great embarrassment for those suffering from it. Patients with this condition experience excessive underarm sweating which does not respond to deodorant, and which often necessitates several changes of clothes every day. Many patients actually develop rashes from overuse of deodorant.
Severe sweating can affect anyone, but usually develops later in life. The cause of primary axillary hyperhidrosis is not yet known, though risk factors include obesity, diabetes, and high blood pressure. The condition can also affect the face, hands and feet.
Aesthetic clinicians are now in a position to help patients with primary axillary hyperhidrosis. The popular neurotoxin Botox, which is most commonly used to treat facial lines and wrinkles, has been FDA approved to treat severe sweating.
Botox is recommended if prescription antiperspirants containing aluminum-based compounds, or other topical agents, are not effective. It is not a recommended treatment for women who are pregnant, who plan to become pregnant, or who are breastfeeding.
How does Botox Treat Primary Axillary Hyperhidrosis?
Botox is injected through a very fine needle into precisely targeted areas to prevent sweat from being produced. The Botox blocks chemical signals from the nerves before these signals reach the sweat glands. These targeted glands temporarily stop producing excessive sweat. All other sweat glands continue to release moisture as normal, thus continuing to cool the body.
Aesthetic clinicians who are given aesthetic injection training can reassure their patients that this Botox treatment is not painful, and if desired, an anesthetic cream can be applied before treatments begin. The treatments take about 10 to 15 minutes. Most patients require about 15 injections during their session.
Botox has a temporary effect, but can safely be repeated. The treatment takes between 5 to7 days to work, and within 4 weeks, patients report a significant reduction in underarm sweating. If any sweat glands were missed in the initial treatment, they can be targeted in additional appointments.
The treatment lasts for 6 months to a year. Clinical studies found that 55 per cent of patients experienced an effective response from Botox treatment. And 81 per cent of patients experienced a greater than 50 per cent reduction in sweating.
Botox treatment is becoming very popular with people who suffer the social implications of excessive sweating, but with business executives worried about excessive sweating during major presentations, or important interviews.